Working… Menu

Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00459277
Recruitment Status : Completed
First Posted : April 11, 2007
Last Update Posted : January 25, 2012
Information provided by (Responsible Party):
Archimedes Development Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2008
Actual Study Completion Date : August 2008
Certification/Extension First Submitted : January 20, 2010